Independence Blue Cross $22.5M Medicare Advantage Settlement, No Consumer Claim Form

Can IBX Members Claim Part of the $22.5 Million?

No. Independence Blue Cross (IBX) agreed to pay $22,500,000 to resolve federal False Claims Act allegations involving inaccurate Medicare Advantage diagnosis data submitted to the Centers for Medicare & Medicaid Services (CMS). The U.S. Department of Justice announced the agreement on September 30, 2026.

This is a government enforcement settlement, not a consumer class action. The money goes to the United States, with a separate $3,825,000 share going to the whistleblower. There is no public claim form and no consumer claim deadline for Medicare patients or IBX members.

The settlement agreement requires IBX to pay $22.5 million, including $11.25 million in restitution, plus interest at 4.25% per year from September 6, 2026 until payment.

The case is United States ex rel. Crawford v. Independence Blue Cross, No. 20-cv-5818, in the U.S. District Court for the Eastern District of Pennsylvania. The government says the alleged conduct involved Medicare Advantage payment years 2017 through 2021.

Quick Facts: IBX Medicare Advantage Settlement

Detail	Information
Company	Independence Blue Cross (IBX)
Settlement amount	$22,500,000
Restitution	$11,250,000
Whistleblower share	$3,825,000 (about 17% of the total)
Case	United States ex rel. Crawford v. Independence Blue Cross
Case number	20-cv-5818
Court	U.S. District Court, Eastern District of Pennsylvania
Law involved	False Claims Act, 31 U.S.C. §§ 3729–3733
Conduct at issue	Medicare Advantage diagnosis and risk-adjustment data
Payment years at issue	2017–2021
Consumer claim form	None
Consumer claim deadline	None announced
Who receives the money	United States; separate payment to the whistleblower
IBX admission of liability	No
Settlement announced	September 30, 2026

The agreement states that IBX denies the government’s allegations and that it is not an admission of liability.

Why There’s No Patient Claim Fund

Many people searching for an “Independence Blue Cross settlement claim” expect a typical consumer class action. This case works differently.

The DOJ settlement resolves allegations that IBX submitted or failed to correct inaccurate diagnosis information used to calculate Medicare Advantage payments. The agreement directs the $22.5 million to the United States. It does not create a fund from which Medicare beneficiaries can file individual claims.

Separately, the United States will pay former IBX employee Suzanne Crawford $3,825,000 as the relator (whistleblower) share after it receives the settlement payment.

You should not submit personal information or pay a fee to any website claiming to process a share of this settlement.

What the Government Alleged

Medicare Advantage plans receive monthly payments from CMS that are adjusted partly by risk factors tied to the expected healthcare costs of their enrollees. Diagnosis information is one input to those calculations.

According to the settlement agreement, IBX ran a chart-review program called “IBX Review.” Nurse reviewers examined medical records for IBX Medicare Advantage enrollees and identified conditions supported by those records. IBX then used the results to submit additional diagnosis codes to CMS. The government contended that some of those codes increased CMS payments to IBX.

The government also alleged that:

• the chart reviews sometimes failed to substantiate diagnosis codes that providers had previously reported;
• IBX did not investigate or withdraw all of those unsupported codes; and
• IBX certified to CMS that its data was accurate, complete and truthful.

These are allegations only. The DOJ is explicit that there has been no determination of liability.

Payment Terms

• Total: $22.5 million paid to the United States.
• Restitution: $11.25 million of the total.
• Interest: 4.25% per year from September 6, 2026 until payment.
• Timing: The agreement requires payment no later than seven days after its Effective Date, defined as the date the last party signs.

The posted signature pages show several dates (for example, IBX’s page is dated September 11, 2026), but the final Effective Date can’t be reliably determined from the document alone. So don’t treat October 1, 2026, or any other date, as a consumer claim deadline or a confirmed payment deadline.

What the Whistleblower Receives

The case began with a qui tam lawsuit filed by former IBX employee Suzanne Crawford on November 18, 2020. The False Claims Act lets qualifying private individuals sue on behalf of the government and potentially receive a share of its recovery. Crawford is entitled to $3,825,000 after the United States receives IBX’s payment.

That’s compensation under the whistleblower provisions. It’s not a patient payment.

Does the Settlement Affect IBX Members’ Billing?

The settlement doesn’t create a patient payment fund, but it does include a provision relevant to beneficiaries. IBX agreed not to seek payment from beneficiaries, their parents, legally responsible individuals or third-party payors for healthcare billings covered by the settlement.

That applies only to the specific “Covered Conduct” defined in the agreement. It is not a blanket cancellation of every bill tied to an IBX Medicare Advantage plan. If you get a bill that seems related to the covered conduct, keep it along with your Medicare and plan records.

Nothing in the settlement terms reviewed changes plan benefits, copays or provider networks, but check your plan documents or contact IBX if you have questions about your own coverage.

What IBX Medicare Advantage Members Should Do

If you were enrolled in an IBX Medicare Advantage plan during the 2017–2021 payment years, you don’t need to file a claim. If you’re concerned about your own records:

1. Keep your Medicare and IBX records. Save Medicare Summary Notices, Explanations of Benefits, medical bills and correspondence.
2. Check your records for errors. Compare your services with your notices and plan records. If a record lists a diagnosis you never received, contact your provider or plan. You can also contact Medicare at 1-800-MEDICARE.
3. Don’t pay anyone for a nonexistent claim. The agreement doesn’t set up a patient claims process.
4. Report suspected fraud when appropriate. The DOJ directs people with information about fraud, waste or abuse in federal healthcare programs to the HHS Office of Inspector General: 1-800-HHS-TIPS (1-800-447-8477).
5. Seek legal advice for individual injuries. The government settlement doesn’t decide whether an individual patient has a separate claim.

The False Claims Act in Brief

The False Claims Act lets the federal government pursue claims involving false or fraudulent requests for government money, and its qui tam provisions let private parties bring cases on the government’s behalf. Here, the government alleged that inaccurate diagnosis information affected Medicare risk-adjustment payments and that IBX failed to withdraw certain unsupported diagnoses and repay resulting overpayments. The settlement resolves those allegations without an admission of liability.

For another healthcare False Claims Act settlement with different facts, see Appleton Medical Clinic Medicare Fraud Settlement, What Wisconsin Patients Need to Know.

Key Dates

Date	Event
November 18, 2020	Suzanne Crawford files the qui tam action
2017–2021	Medicare Advantage payment years identified in the settlement
September 6, 2026	Interest on the settlement amount begins under the agreement
September 11, 2026	Date on IBX’s signature page
September 30, 2026	DOJ announces the $22.5 million settlement
Settlement payment deadline	Seven days after the agreement’s Effective Date
Consumer claim deadline	None. No patient claim process established.

Frequently Asked Questions

Is there an Independence Blue Cross $22.5 million settlement?

Yes. IBX agreed to pay $22,500,000 to resolve federal False Claims Act allegations about Medicare Advantage diagnosis information.

Can IBX Medicare Advantage members file a claim?

No. No public patient claim process has been established. The payment goes to the United States, with a separate $3,825,000 share to the whistleblower.

What is the settlement deadline?

There is no consumer claim deadline. For IBX’s payment to the government, the agreement requires payment within seven days of its Effective Date, but the exact calendar date can’t be reliably determined from the posted signature pages.

Who is eligible?

There’s no eligibility category for individual consumers. This is a federal False Claims Act enforcement matter between IBX and the United States.

What did IBX allegedly do?

The government alleged IBX submitted inaccurate diagnosis information to CMS, failed to withdraw certain unsupported diagnosis codes and falsely certified the accuracy of its data. The allegations cover payment years 2017–2021.

Did IBX admit Medicare fraud?

No. The agreement states IBX denies the allegations and that it is not an admission of liability. The DOJ says there has been no determination of liability.

How much does the whistleblower receive?

$3,825,000, paid to Suzanne Crawford after the United States receives the settlement amount.

How much is restitution?

$11.25 million of the $22.5 million.

Do IBX members get a settlement check?

Not under this agreement. It doesn’t create a public fund for individual payments.

What if a medical record or diagnosis on my plan summary is wrong?

Keep the records and contact your provider, your plan or Medicare (1-800-MEDICARE). If you believe you suffered a separate legal injury, consider advice from a licensed attorney.

Where can I report suspected Medicare fraud?

To the HHS Office of Inspector General at 1-800-HHS-TIPS (1-800-447-8477).

Is the whistleblower’s award taxable?

Generally, yes. Whistleblower awards are typically taxable income. That is separate from anything affecting patients, and recipients should consult a tax professional.

Bottom Line

Independence Blue Cross agreed to pay $22.5 million to resolve False Claims Act allegations about Medicare Advantage diagnosis and risk-adjustment data for payment years 2017 through 2021. The settlement includes $11.25 million in restitution and a $3.825 million whistleblower share for former IBX employee Suzanne Crawford.

It is not a consumer class action. Medicare beneficiaries have no claim form to complete and no consumer deadline. The agreement also states that IBX will not seek payment from beneficiaries or certain others for healthcare billings covered by the settlement’s defined Covered Conduct. As always, the settlement resolves allegations, and the DOJ states there has been no determination of liability.

This article is for informational purposes only and is not legal advice. The settlement resolves allegations and is not a judicial finding of liability. Court documents and the settlement agreement control if they differ from this summary.

Sources & Primary Documents

1. U.S. Department of Justice, Eastern District of Pennsylvania, “Independence Blue Cross Agrees to Pay $22.5 Million to Resolve Allegations That It Violated the False Claims Act by Submitting or Failing to Correct Inaccurate Diagnoses for Medicare Advantage Enrollees”: https://www.justice.gov/usao-edpa/pr/independence-blue-cross-agrees-pay-225-million-resolve-allegations-it-violated-false
2. U.S. Department of Justice, Settlement Agreement, United States ex rel. Crawford v. Independence Blue Cross, No. 20-cv-5818 (E.D. Pa.): https://www.justice.gov/opa/media/1463421/dl
3. U.S. Department of Justice, Office of Public Affairs, “Independence Blue Cross to Pay $22.5M to Resolve False Claims Act Allegations”: https://www.justice.gov/index.php/opa/pr/independence-blue-cross-pay-225m-resolve-false-claims-act-allegations

By Israr Ahmad, Legal Content Researcher